HCWB is trading at $5.70 (8.45% up) after HCW Biologics announced it regained Nasdaq bid-price compliance and will execute a 1-for-6 reverse stock split.
- The reverse split is intended to maintain listing compliance following a Nasdaq Hearings Panel decision.
- The company expects to complete the split on June 30, 2026, and will begin trading on a split-adjusted basis at the market open.